Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus fentanyl for perioperative hemodynamics and emergence in glossectomy
PACTR202509822488978Phase 2Completed
- Sponsor
- National Cancer Institute, Cairo University
- Start
- Jan 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and fentanyl in Not applicable (2 arms), sponsored by National Cancer Institute, Cairo University. Primary endpoint: Quality of emergence. Started Jan 2024; status: completed.
02
Drugs
dexmedetomidinefentanyl
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR202509822488978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509822488978.